Mainly focused on PEG technology designed to improve the safety,
efficacy and dosing characteristics of genes, proteins, peptides,
antibodies, anticancer agents, and viruses.

1) Highly Reactive and hydrophobic PEG derivatives
    for conjugating to therapeutic proteins
2) PEG copolymers with enhancing cell trafficking
3) Site-specific PEGylation of therapeutic proteins and peptides
4) Hepatocyte targeting PEGylated drugs
5) Development of highly effective siRNA delivery system